Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine vs Orthokeratology in Pediatric Myopia (AVO)
NCT05478356Unknown
- Sponsor
- Evidence Based Cataract Study Group
- Start
- Aug 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, open-label trial of NVK002 in myopia, sponsored by Evidence Based Cataract Study Group. Primary endpoints: Progression of myopia at 1 year and Progression of axial length at 1 year. Status: unknown.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT05478356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05478356.